Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
endonuclease IV | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
pregnane X receptor | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
GLS protein | 4 | 0 | 0 | 4 |
TDP1 protein | 6 | 0 | 0 | 6 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
AR protein | 8 | 0 | 0 | 8 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
progesterone receptor | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 8 | 0 | 0 | 8 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
geminin | 5 | 0 | 0 | 5 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 4 | 3 | 2 | 9 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Glucocorticoid receptor | 0 | 4 | 1 | 10 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit delta | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 3 | 2 | 9 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 3 | 2 | 9 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 3 | 2 | 9 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
GABA theta subunit | 4 | 3 | 2 | 9 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 4 | 3 | 2 | 9 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
G | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Interferon beta | 4 | 0 | 0 | 4 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 2 |
Albumin | 0 | 0 | 1 | 1 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
ATP-dependent translocase ABCB1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 3 | 6 |
Translocator protein | 0 | 1 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 2 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 2 | 5 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 3 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Luciferase | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
Thrombopoietin | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 2 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 2 | 4 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
GALC protein | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 3 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |